Another bad quarterly as expected. No real update on when the foxconn manufacturing will start, which is the only time I can see this possibly turning around. Have to assume this quarter now but much later than thought. Spirosonic cleared for sale in the US. I would have thought that would have been announced when it happened rather than included in one sentence in a quarterly. Good to see some money going to marketing and sales but has it helped. No info re this ehealth that was supposed give first revenue this half from memory.
Add to My Watchlist
What is My Watchlist?
